INCOME TAXES (Tables)
|
12 Months Ended |
Mar. 30, 2024 |
Income Tax Disclosure [Abstract] |
|
Schedule of Provision for Income Taxes, Income Before Income Taxes |
The provision for income taxes was computed based on the following amounts of income from continuing operations before income taxes:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended March |
|
|
|
|
|
|
|
|
(In thousands) |
|
2024 |
|
|
2023 |
|
2022 |
Domestic |
|
$ |
(970,325) |
|
|
|
$ |
(885,562) |
|
|
$ |
518,386 |
|
Foreign |
|
736,640 |
|
|
|
928,849 |
|
|
1,004,864 |
|
Income (loss) before income taxes |
|
$ |
(233,685) |
|
|
|
$ |
43,287
|
|
|
$ |
1,523,250
|
|
|
Schedule of Provision for Income Taxes |
The provision for income taxes consisted of:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended March |
|
|
|
|
|
|
|
|
(In thousands) |
|
2024 |
|
|
2023 |
|
2022 |
Current: |
|
|
|
|
|
|
|
Federal |
|
$ |
236,135 |
|
|
|
$ |
(114,772) |
|
|
$ |
231,469 |
|
Foreign |
|
759,679 |
|
|
|
106,192 |
|
|
196,540 |
|
State |
|
134,483 |
|
|
|
(13,163) |
|
|
36,461 |
|
|
|
1,130,297 |
|
|
|
(21,743) |
|
|
464,470 |
|
Deferred: |
|
|
|
|
|
|
|
Federal and state |
|
(316,470) |
|
|
|
(46,677) |
|
|
(177,381) |
|
Foreign |
|
(78,630) |
|
|
|
(6,877) |
|
|
19,892 |
|
|
|
(395,100) |
|
|
|
(53,554) |
|
|
(157,489) |
|
Income tax expense (benefit) |
|
$ |
735,197
|
|
|
|
$ |
(75,297) |
|
|
$ |
306,981
|
|
|
Schedule of Differences Between Income Taxes Computed by Applying Statutory Federal Income Tax Rate and Income Tax Expense reported in Consolidated Financial Statements |
The differences between income taxes computed by applying the statutory federal income tax rate and income tax expense (benefit) reported in the consolidated financial statements are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended March |
|
|
|
|
|
|
|
|
(In thousands) |
|
2024 |
|
|
2023 |
|
2022 |
Tax at federal statutory rate |
|
$ |
(49,074) |
|
|
|
$ |
9,090 |
|
|
$ |
319,882 |
|
State income taxes, net of federal tax benefit |
|
(28,867) |
|
|
|
(17,301) |
|
|
16,641 |
|
Foreign rate differences |
|
54,941 |
|
|
|
(38,609) |
|
|
(62,928) |
|
Tax reform |
|
— |
|
|
|
(94,877) |
|
|
67,358 |
|
Tax litigation |
|
691,053 |
|
|
|
— |
|
|
— |
|
Goodwill impairment |
|
55,076 |
|
|
|
74,624 |
|
|
— |
|
|
|
|
|
|
|
|
|
Stock compensation |
|
3,908 |
|
|
|
2,304 |
|
|
(1,977) |
|
Non-taxable contingent consideration adjustments |
|
— |
|
|
|
— |
|
|
(28,090) |
|
Interest on tax receivable |
|
11,972 |
|
|
|
(11,972) |
|
|
— |
|
Other |
|
(3,812) |
|
|
|
1,444 |
|
|
(3,905) |
|
Income tax expense (benefit) |
|
$ |
735,197
|
|
|
|
$ |
(75,297) |
|
|
$ |
306,981
|
|
|
Schedule of Deferred Income Tax Assets and Liabilities |
Deferred income tax assets and liabilities consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In thousands) |
|
March 2024 |
|
|
March 2023 |
|
|
|
|
|
|
|
|
|
Deferred income tax assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Inventories |
|
$ |
88,299 |
|
|
|
$ |
74,395 |
|
|
|
|
|
|
|
|
|
|
Depreciation and capitalized research and development |
|
12,785 |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
Deferred compensation |
|
19,904 |
|
|
|
24,557 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock compensation |
|
26,961 |
|
|
|
27,589 |
|
|
|
|
|
|
|
|
|
|
Operating lease liabilities |
|
352,821 |
|
|
|
361,676 |
|
|
|
|
|
|
|
|
|
|
Other employee benefits |
|
3,170 |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
Other accrued expenses |
|
117,689 |
|
|
|
109,050 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense limitation carryforward |
|
143,077 |
|
|
|
3,932 |
|
|
|
|
|
|
|
|
|
|
Capital loss carryforwards |
|
153,789 |
|
|
|
166,587 |
|
|
|
|
|
|
|
|
|
|
Operating loss and credit carryforwards |
|
557,272 |
|
|
|
331,167 |
|
|
|
|
|
|
|
|
|
|
Gross deferred income tax assets |
|
1,475,767 |
|
|
|
1,098,953 |
|
|
|
|
|
|
|
|
|
|
Valuation allowances |
|
(436,047) |
|
|
|
(424,932) |
|
|
|
|
|
|
|
|
|
|
Net deferred income tax assets |
|
1,039,720 |
|
|
|
674,021 |
|
|
|
|
|
|
|
|
|
|
Deferred income tax liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and capitalized research and development |
|
— |
|
|
|
26,303 |
|
|
|
|
|
|
|
|
|
|
Intangible assets |
|
120,682 |
|
|
|
277,473 |
|
|
|
|
|
|
|
|
|
|
Operating lease right-of-use assets |
|
320,896 |
|
|
|
330,235 |
|
|
|
|
|
|
|
|
|
|
Other employee benefits |
|
— |
|
|
|
3,707 |
|
|
|
|
|
|
|
|
|
|
Outside basis difference in subsidiaries |
|
216,215 |
|
|
|
46,690 |
|
|
|
|
|
|
|
|
|
|
Other deferred tax liabilities |
|
2,224 |
|
|
|
2,042 |
|
|
|
|
|
|
|
|
|
|
Deferred income tax liabilities |
|
660,017 |
|
|
|
686,450 |
|
|
|
|
|
|
|
|
|
|
Net deferred income tax assets (liabilities) |
|
$ |
379,703
|
|
|
|
$ |
(12,429) |
|
|
|
|
|
|
|
|
|
|
Amounts included in the Consolidated Balance Sheets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other assets (Note 11) |
|
$ |
389,783 |
|
|
|
$ |
95,117 |
|
|
|
|
|
|
|
|
|
|
Other liabilities (Note 16) |
|
(10,080) |
|
|
|
(107,546) |
|
|
|
|
|
|
|
|
|
|
|
|
$ |
379,703
|
|
|
|
$ |
(12,429) |
|
|
|
|
|
|
|
|
|
|
|
Schedule of Reconciliation of Change in Accrual for Unrecognized Income Tax Benefits |
A reconciliation of the change in the accrual for unrecognized income tax benefits is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In thousands) |
Unrecognized Income Tax Benefits |
|
Accrued Interest and Penalties |
|
Unrecognized Income Tax Benefits Including Interest and Penalties |
|
Balance, March 2021 |
$ |
223,010
|
|
|
$ |
38,141
|
|
|
$ |
261,151
|
|
|
Additions for current year tax positions |
28,098 |
|
|
— |
|
|
28,098 |
|
|
Additions for prior year tax positions (a)
|
112,850 |
|
|
32,642 |
|
|
145,492 |
|
|
Reductions for prior year tax positions |
(895) |
|
|
(532) |
|
|
(1,427) |
|
|
Reductions due to statute expirations |
(5,803) |
|
|
(840) |
|
|
(6,643) |
|
|
Payments in settlement |
(21,278) |
|
|
(730) |
|
|
(22,008) |
|
|
Decrease due to divestiture |
(506) |
|
|
(340) |
|
|
(846) |
|
|
|
|
|
|
|
|
|
Currency translation |
186 |
|
|
(43) |
|
|
143 |
|
|
Balance, March 2022 |
335,662
|
|
|
68,298
|
|
|
403,960
|
|
|
Additions for current year tax positions |
22,319 |
|
|
— |
|
|
22,319 |
|
|
Additions for prior year tax positions |
13,324 |
|
|
20,577 |
|
|
33,901 |
|
|
Reductions for prior year tax positions |
(3,747) |
|
|
(951) |
|
|
(4,698) |
|
|
Reductions due to statute expirations |
(15,369) |
|
|
(1,699) |
|
|
(17,068) |
|
|
Payments in settlement |
(3,847) |
|
|
(1,608) |
|
|
(5,455) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Currency translation |
(172) |
|
|
(10) |
|
|
(182) |
|
|
Balance, March 2023 |
348,170
|
|
|
84,607
|
|
|
432,777
|
|
|
Additions for current year tax positions |
15,982 |
|
|
— |
|
|
15,982 |
|
|
Additions for prior year tax positions (b)
|
165,426 |
|
|
78,133 |
|
|
243,559 |
|
|
Reductions for prior year tax positions |
(36,943) |
|
|
(3,809) |
|
|
(40,752) |
|
|
Reductions due to statute expirations |
(1,436) |
|
|
(383) |
|
|
(1,819) |
|
|
Payments in settlement (c)
|
(210,874) |
|
|
(74,659) |
|
|
(285,533) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Currency translation |
(11) |
|
|
(4) |
|
|
(15) |
|
|
Balance, March 2024 |
$ |
280,314
|
|
|
$ |
83,885
|
|
|
$ |
364,199
|
|
|
(a)The year ended March 2022 included an increase resulting from updated estimates related to intellectual property transfers completed in a prior period.
(b)The year ended March 2024 includes an increase due to uncertainty in the application of court decisions upheld upon appeal.
(c)The year ended March 2024 includes a settlement with the tax authorities related to intellectual property transfers completed in a prior period.
|
Schedule of Amounts Included in Consolidated Balance Sheets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In thousands) |
|
March 2024 |
|
|
March 2023 |
Amounts included in the Consolidated Balance Sheets (a):
|
|
|
|
|
|
Unrecognized income tax benefits, including interest and penalties |
|
$ |
364,199 |
|
|
|
$ |
432,777 |
|
Less deferred tax benefits |
|
61,368 |
|
|
|
135,175 |
|
Total unrecognized tax benefits |
|
$ |
302,831
|
|
|
|
$ |
297,602
|
|
(a)Included in the accrued liabilities and other liabilities line items in the Consolidated Balance Sheets.
|